Acute Exercise and NK Cell Regulation in Tissue and Circulation After IL-6R Blockade

NCT04616235 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Interleukin-6 Inhibition
Physical Stress
Appetitive Behavior

Interventions

DRUG: Tocilizumab Injectable Product
OTHER: Saline 0.9% 100 ml NaCl 0.9% will be infused over 1 hour

Sponsor

Rigshospitalet, Denmark